Skip to main content
SpringerLink
Log in

OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The organic anion transporter peptides (OATP) 1B1 and 1B3 are hepatocytic-specific transporters determinant for the uptake of the contrast media Gd-EOB-DTPA during magnetic resonance, but variably lost in hepatocellular carcinoma (HCC). Here, we studied a series of HCCs from livers that underwent liver transplantation (OLT) and correlated the expression of OATP 1B1/1B3 with HCC morphological features and the expression of the biliary-type keratins K7 and K19, the latter previously correlated with a worse prognosis after OLT. Seventy-five HCCs from 69 OLT patients were evaluated by histology and immunohistochemistry with monoclonal antibodies against OATP 1B1/1B3, K7, and K19. Histopathological and immunohistochemical features were therefore compared to recipient follow-up data. Thirty-four (45%) HCCs were completely OATP−, and 18 (24%) showed positivity for K7 and/or K19. We observed a significant inverse correlation between OATP and K7/19 expression (P < 0.001): all OATP+ cases were K7/19−, while all K7+ and/or K19+ cases were OATP−. Sixteen cases were negative for all antibodies. No correlation was found between histopathological features and immunohistochemistry. Twenty-five recipients experienced HCC recurrence, and ten died from neoplastic recurrence. Neither OATP nor keratin expressions were correlated with HCC recurrence, while OATP negativity significantly correlated with HCC-related death after recurrence (P = 0.036). In conclusion, HCCs show a progressive loss in OATP immunoreactivity that correlates with the gain of a biliary phenotype. Although further studies are required to define these findings better, our results support the idea that OATP could be used together with K7/19 to identify a phenotypical “spectrum” in HCC progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

    Article  PubMed  Google Scholar 

  2. Xu LB, Wang J, Liu C, Pang HW, Chen YJ, Ou QJ, Chen JS (2010) Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery. World J Gastroenterol 16:5257–5262

    Article  PubMed  Google Scholar 

  3. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intrarterial injection of contrast material. Radiology 225:143–149

    Article  PubMed  Google Scholar 

  4. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma J (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976

    PubMed  CAS  Google Scholar 

  5. Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L (2010) The impact of vascular and non vascular findings on the non invasive diagnosis of small hepatocellular carcinoma based on EASL and AASLD criteria. Am J Gastroenterol 105:599–609

    Article  PubMed  Google Scholar 

  6. Cui Y, König J, Nies AT, Pfannschmidt M, Hergt M, Franke WW, Alt W, Moll R, Keppler D (2003) Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest 83:527–538

    PubMed  CAS  Google Scholar 

  7. Kalliokoski A, Niemi M (2009) Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693–705

    Article  PubMed  CAS  Google Scholar 

  8. Oswald M, Kullak-Ublick GA, Paumgartner G, Beuers U (2001) Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 21:247–253

    Article  PubMed  CAS  Google Scholar 

  9. Kojima H, Nies AT, König J, Hagmann W, Spring H, Uemura M, Fukui H, Keppler D (2003) Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 39:693–702

    Article  PubMed  CAS  Google Scholar 

  10. Dumont M, Jacquemin E, D’Hont C, Descout C, Cresteil D, Haouzi D, Desrochers M, Stieger B, Hadchouel M, Erlinger S (1997) Expression of the liver Na + −independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 27:1051–1056

    Article  PubMed  CAS  Google Scholar 

  11. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, Hesse T, Berns T, Peters PE (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183

    PubMed  CAS  Google Scholar 

  12. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, Taura K, Yasuchika K, Nitta T, Ikai I, Uemoto S (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798

    Article  PubMed  CAS  Google Scholar 

  13. Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792

    PubMed  CAS  Google Scholar 

  14. Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833

    Article  PubMed  Google Scholar 

  15. Kinoshita M, Miyata M (2002) Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36:433–438

    Article  PubMed  CAS  Google Scholar 

  16. Vee ML, Lecureur V, Stieger B, Fardel O (2009) Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37:685–693

    Article  PubMed  Google Scholar 

  17. Vee ML, Gripon P, Stieger B, Fardel O (2008) Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 36:217–222

    Article  PubMed  Google Scholar 

  18. Vavricka SR, Jung D, Fried M, Grützner U, Meier PJ, Kullak-Ublick GA (2004) The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma. J Hepatol 40:212–218

    Article  PubMed  CAS  Google Scholar 

  19. Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 149:1167–1175

    PubMed  CAS  Google Scholar 

  20. Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49:138–151

    Article  PubMed  CAS  Google Scholar 

  21. Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, Tanaka S, Kaneda K, Hirohashi K (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94:851–857

    Article  PubMed  CAS  Google Scholar 

  22. D’Errico A, Baccarini P, Fiorentino M, Ceccarelli C, Bonazzi C, Ponzetto A, Scoazec JY, Mancini AM, Grigioni WF (1996) Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Pathol 27:599–604

    Article  PubMed  Google Scholar 

  23. Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52:224–232

    Article  PubMed  CAS  Google Scholar 

  24. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  CAS  Google Scholar 

  25. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503

    Article  PubMed  CAS  Google Scholar 

  26. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L (1985) Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 55:124–135

    Article  PubMed  CAS  Google Scholar 

  27. Roncalli M, Park YN, Di Tommaso L (2010) Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 42S:S228–S234

    Article  Google Scholar 

  28. Kudo M (2010) Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 78(Suppl 1):87–93

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Pathology Unit, “F. Addarii” Institute of Oncology and Pathology, S. Orsola-Malpighi Hospital, Viale Ercolani 4/2, 40138, Bologna, Italy

    Francesco Vasuri, Michelangelo Fiorentino, Elisa Capizzi, Walter F. Grigioni & Antonia D’Errico-Grigioni

  2. Radiology Unit, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy

    Rita Golfieri & Matteo Renzulli

  3. Unit of General and Transplantation Surgery, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy

    Antonio D. Pinna

Authors
  1. Francesco Vasuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita Golfieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michelangelo Fiorentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisa Capizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matteo Renzulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Antonio D. Pinna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Walter F. Grigioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Antonia D’Errico-Grigioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonia D’Errico-Grigioni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasuri, F., Golfieri, R., Fiorentino, M. et al. OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Virchows Arch 459, 141–146 (2011). https://doi.org/10.1007/s00428-011-1099-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-011-1099-5

Keywords

Search

Navigation